Xvivo Perfusion AB's total assets for Q1 2025 were kr2.30B, a decrease of -4.48% from the previous quarter. XVIPF total liabilities were kr202.68M for the fiscal quarter, a -17.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.